Inventor
BUTTAR DAVID
GB11 patents
⚠️ This page may combine multiple inventors who share the name “BUTTAR DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
6 patentsUS7737149B2Jun 15, 2010
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
ASTRAZENECA AB17 citations91
US9155727B2Oct 13, 2015
Chemical compounds
ASTRAZENECA AB5 citations79
US9688640B2Jun 27, 2017
Methods of treating cancer with a pyrazole derivative
ASTRAZENECA AB2 citations71
US10301267B2May 28, 2019
Compounds
ASTRAZENECA AB0 citations51
US10130617B2Nov 20, 2018
Chemical compounds
ASTRAZENECA AB0 citations46
US9616050B2Apr 11, 2017
Chemical compounds
ASTRAZENECA AB0 citations46
DIZAL JIANGSU PHARMACEUTICAL CO LTD
3 patentsUS11084827B2Aug 10, 2021
Triazolopyrimidine compounds and their use in treating cancer
DIZAL JIANGSU PHARMACEUTICAL CO LTD1 citations69
US12503473B2Dec 23, 2025
Triazolopyrimidine compounds and their use in treating cancer
DIZAL JIANGSU PHARMACEUTICAL CO LTD0 citations59
US11851432B2Dec 26, 2023
Triazolopyrimidine compounds and their use in treating cancer
DIZAL JIANGSU PHARMACEUTICAL CO LTD0 citations59
FOOTE KEVIN MICHAEL
2 patentsUS8129391B2Mar 6, 2012
N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
FOOTE KEVIN MICHAEL12 citations90
US8604022B2Dec 10, 2013
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
FOOTE KEVIN MICHAEL8 citations82